Suraksha Clinic and Diagnostic Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | November 29, 2024 to December 3, 2024 |
| Listing Date | [.] |
| Face Value | ₹ 2 per share |
| Price Band | ₹ 420 to ₹ 441 per share |
| Lot Size | 34 Shares |
| Total Issue Size | 1,91,89,330 shares (aggregating up to ₹ 846.25 Cr) |
| Offer for Sale | 1,91,89,330 shares of ₹2 (aggregating up to ₹ 846.25 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Shareholding pre issue | 5,20,80,758 |
About Suraksha Clinic and Diagnostic Limited IPO
Incorporated in 2005, Suraksha Diagnostic Limited has emerged as a leading provider of pathology, radiology testing, and medical consultancy services across India. The company boasts an extensive network, including a central reference laboratory supported by eight satellite laboratories and 215 customer touchpoints. This includes 49 state-of-the-art diagnostic centres and 166 strategically located sample collection centres, spanning the regions of West Bengal, Bihar, Assam, and Meghalaya as of June 30, 2024.
Suraksha Diagnostic Limited is committed to offering both online and offline medical consultation services, seamlessly integrated under one roof. They operate 44 advanced diagnostic centres that house 120 polyclinics, collaborating with a robust team of over 750 highly qualified doctors. This integrated approach ensures that patients receive comprehensive care from diagnosis to consultation, enhancing the overall healthcare experience.
The company’s operations are underpinned by cutting-edge technology platforms designed to streamline processes and enhance efficiency. Key systems include the Laboratory Information Management System (LIMS), a fully integrated Radiology Information System (RIS), the Picture Archive Communication System (PACS), and an Enterprise Resource Planning System (ERP). These systems enable seamless data management and efficient service delivery, ultimately benefiting patients and healthcare professionals alike.
In addition to diagnostic services, Suraksha Diagnostic Limited offers vaccination services and customized testing packages aimed at disease prediction and early detection. Utilizing digital pathology and artificial intelligence, the company generates accurate and timely blood tests. Furthermore, all radiology reporting is conducted through a sophisticated digital platform, which allows for rapid case reporting from any diagnostic centre, significantly reducing turnaround time and ensuring prompt medical intervention.
Suraksha Diagnostic Limited continues to innovate and expand its services, setting new benchmarks in the healthcare industry and reaffirming its commitment to excellence in patient care.
Suraksha Clinic and Diagnostic Limited IPO Overview:
- IPO Type: Book Built Issue
- Total Issue Size: ₹846.25 crores
- Offer Details: The IPO is entirely an Offer for Sale (OFS), with 1.92 crore shares being offered for sale by the existing shareholders.
- Price Band ₹420 to ₹441 per share
- Minimum Lot Size: The minimum lot size for an application is 34 shares.
- Issue Opening Date: November 29, 2024ssue Closing Date: December 3, 2024
- Book Running Lead Managers: ICICI Securities Limited, Nuvama Wealth Management Limited, SBI Capital Markets Limited
- Registrar: Kfin Technologies Limited
Suraksha Clinic and Diagnostic Limited IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Net Offer |
Suraksha Clinic and Diagnostic IPO Objective:
- The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Clinic and Diagnostic Limited IPO Financial Information
Latest Revenue
₹ 61.85 Cr
Profit After Tax
₹ 7.67 Cr
Net Worth
₹ 187.05 Cr
Total Borrowing
₹ 7.57 Cr
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 30 June 2024 | 314.20 | 61.85 | 7.67 | 187.05 | 7.57 |
| 31 Mar 2024 | 300.21 | 222.26 | 23.13 | 179.41 | 8.64 |
| 31 Mar 2023 | 281.20 | 193.69 | 6.07 | 155.93 | 14.01 |
| 31 Mar 2022 | 275.96 | 225.77 | 20.82 | 145.84 | 19.03 |
| Amount in ₹ Crore | |||||
Suraksha Clinic and Diagnostic Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 14.09% |
| ROCE | 21.46% |
| RoNW | 14.09% |
| Debt/Equity | 0.2 |
| P/BV | 13.1 |
| PAT Margin (%) | 10.57 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.44 | - |
| P/E (x) | 99.31 | - |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The INDIA IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India.
Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source.
Well-invested and technologically advanced clinical infrastructure.
Commitment to quality driving high individual consumer business share and customer retention.
Management team with relevant industry experience.
Download regulatory filings
Suraksha Clinic and Diagnostic Limited IPO Timeline
| IPO Open Date | Friday, November 29, 2024 |
| IPO Close Date | Tuesday, December 3, 2024 |
| Basis of Allotment | Wednesday, December 4, 2024 |
| Initiation of Refunds | Thursday, December 5, 2024 |
| Credit of Shares to Demat | Thursday, December 5, 2024 |
| Listing Date | Friday, December 6, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 3, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹ 14,994 |
| Retail (Max) | 13 | 442 | ₹ 1,94,922 |
| S-HNI (Min) | 14 | 476 | ₹ 2,09,916 |
| S-HNI (Max) | 66 | 2,244 | ₹ 9,89,604 |
| B-HNI (Min) | 67 | 2,278 | ₹ 10,04,598 |